|
|
Post by goyocafe on Sept 18, 2021 11:15:47 GMT -5
|
|
|
|
Post by nylefty on Sept 18, 2021 12:37:14 GMT -5
Errors in inhalation techniques occur in a percentage of 6.8–43.2%, and only 10–52% of physicians are
adequately informed regarding proper device use [38,39]. The most common clinically
significant errors include incorrect positioning of both the device and the head, failure (i)
to insert and pierce the capsule (for the capsule-based DPIs), (ii) to exhale away from the
device prior to inhalation, (iii) to hold the breath after inhalation, and (iv) to maintain a
forceful and deep inspiration. Incorrect inhaler actuation techniques can be associated
with patient-related factors, such as age, sex, health condition, and education level [40,41].
A study of a total of 2288 records highlighted that, independent of the type of inhaler used,
the strongest association was found between inhaler misuse and older age, lower level of
schooling, and inadequate instructions by healthcare providers [42]. As expected, elderly
patients with comorbidities, such as Parkinson’s disease and dementia, may be more susceptible to handling errors compared with healthy or younger patients [38].
|
|
|
|
Post by goyocafe on Sept 18, 2021 13:00:53 GMT -5
|
|
|
|
Post by itellthefuture777 on Sept 18, 2021 13:37:57 GMT -5
It looks like there where Bluhale fits
|
|
|
|
Post by MnkdWASmyRtrmntPlan on Sept 18, 2021 15:40:30 GMT -5
I wonder why technosphere wasn't reviewed. This is all there was:
Another recent technology, Technosphere® (MannKind Corporation, Westlake Village,
CA, USA), consists of a DDS-based on fumaryl diketopiperazine microparticles,
which are self-assembled in a mild acidic medium to form microspheres with high porosity
and surface area that can be administered without the addition of carrier particles [17].
|
|
